EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Triacetin and a Mushroom Blend Restore Butyrate Production by IBS Microbiomes Ex Vivo, Thus Promoting Barrier Integrity

Pieter Van den Abbeele iD, Jonas Poppe, Aurélien Baudot iD, Lam Dai Vu

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199388 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Pieter Van den Abbeele und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cryptobiotix SA, Technologiepark-Zwijnaarde 82, 9052 Ghent, Belgium. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Gastrointestinal Microbiome, Butyrates, Agaricales. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Compound Solutions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder, characterized by abdominal pain, altered bowel habits (diarrhea and/or constipation) and a dysbiosis of the gut microbiome. This dysbiosis is difficult to restore via fiber supplementation, which typically promotes gas production, potentially worsening IBS symptoms. We therefore studied how two novel products, triacetin (TA; REBiome™) and a mushroom blend (MB; Hōlistiq™), modulate the microbiome of IBS subjects (n = 8) using the ex vivo SIFR® (Systemic Intestinal Fermentation Research) technology combined with a co-culture of epithelial/immune (Caco-2/THP-1) cells. First, the IBS microbiomes revealed large interpersonal variability and an IBS-associated dysbiosis. TA increased the beneficial metabolites acetate and butyrate (~Anaerobutyricum soehngenii, Mediterraneibacter_A butyricigenes, Faecalibacterium prausnitzii). Moreover, MB stimulated a wide range of gut microbes and additionally promoted propionate. Despite more strongly increasing total short-chain fatty acid (SCFA) levels, TA induced significantly less gas production than MB. Mechanistically, acetate with TA was derived from hydrolysis, a process that indeed does not induce gas production. Notably, both TA and MB enhanced gut barrier integrity (transepithelial electrical TEER), which is related to lower symptom severity in IBS patients. Overall, our findings highlight the product-specific microbiome modulation and potential of MB, TA or combinations thereof as dietary interventions for managing IBS symptom severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeGastrointestinal MicrobiomeButyratesAgaricalesHumansMaleFemaleAdultMiddle AgedCaco-2 CellsFatty Acids, VolatileIntestinal MucosaDysbiosisFermentation

Stichwörter der Autor:innen

IBSSCFASIFRbarrier integritybutyratemushroomprebiotictriacetin

Substanzen

ButyratesFatty Acids, Volatile

Autor:innen und Institutionen

  • Cryptobiotix SA, Technologiepark-Zwijnaarde 82, 9052 Ghent, Belgium.

ORCID-Profile: Pieter Van den Abbeele, Aurélien Baudot

Förderung

  • Compound Solutions

Zitieren

APA

Van den Abbeele, P., Poppe, J., Baudot, A., & Vu, L. D. (2025). Triacetin and a Mushroom Blend Restore Butyrate Production by IBS Microbiomes Ex Vivo, Thus Promoting Barrier Integrity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199388

Vancouver

Van den Abbeele P, Poppe J, Baudot A, Vu LD. Triacetin and a Mushroom Blend Restore Butyrate Production by IBS Microbiomes Ex Vivo, Thus Promoting Barrier Integrity. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199388

BibTeX
@article{VandenAbbeele2025,
  author = {Van den Abbeele, Pieter and Poppe, Jonas and Baudot, Aurélien and Vu, Lam Dai},
  title = {Triacetin and a Mushroom Blend Restore Butyrate Production by IBS Microbiomes Ex Vivo, Thus Promoting Barrier Integrity},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199388}
}
Kostenlos starten →